# AZD8330 First Time in Man in Patients With Advanced Malignancies

> **NCT00454090** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 83 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** AZD8330

## Key facts

- **NCT ID:** NCT00454090
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-10
- **Final completion:** 2011-03
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2011-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454090, "AZD8330 First Time in Man in Patients With Advanced Malignancies". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00454090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*